Atopic Dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1).Age = 12 years; (2).The clinical diagnosis of atopic dermatitis is that the disease severity meets the criteria of mild (<=7 points) and moderate (7 to <=21 points) according to the Eczema Area and Severity Index (EASI). (3).The last use of topical drug was at least 3 days before study entry; (4).The patient was informed and signed the consent form.
Exclusion criteria
Exclusion criteria: (1).For patients with severe and extensive skin lesions, topical medications alone may be difficult to control the condition and systemic treatment should be considered; (2).Severe skin infection or oozing in the area of ??atopic dermatitis; (3).Patients with other serious primary diseases or systemic diseases (such as heart, liver, kidney, brain, blood and other systemic diseases), as well as mental illness and malignant tumors; (4).Patients with other skin diseases who require combined treatment; (5).Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eczema area and severity index; | — |
Secondary
| Measure | Time frame |
|---|---|
| The investigator's global assessment;Peak pruritus numeric rating scale;Patient oriented eczema measure;Dermatology life quality index;Stratum Corneum Hydration;Transepidermal Water Loss;Assessment of sleep reduction; | — |
Countries
China
Contacts
Guangzhou Dermatology Hospital